Jane Yeo

1.7k total citations
13 papers, 768 citations indexed

About

Jane Yeo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jane Yeo has authored 13 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Jane Yeo's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Herpesvirus Infections and Treatments (5 papers). Jane Yeo is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Herpesvirus Infections and Treatments (5 papers). Jane Yeo collaborates with scholars based in United Kingdom, United States and Germany. Jane Yeo's co-authors include A. P. Fiddian, Robin Wood, Dirk Schürmann, Joseph Gathe, Cindy Garris, Andrzej Gładysz, Edwin DeJesus, Prudence Ive, Nicholaos Bellos and Jaime E. Hernández and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Jane Yeo

13 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Yeo United Kingdom 13 493 350 330 177 78 13 768
P. de Truchis France 10 351 0.7× 251 0.7× 201 0.6× 147 0.8× 22 0.3× 20 589
John Chuah Australia 14 479 1.0× 382 1.1× 255 0.8× 281 1.6× 29 0.4× 18 697
Heribert Knechten Germany 15 512 1.0× 435 1.2× 170 0.5× 117 0.7× 8 0.1× 44 691
Terri Creagh-Kirk United States 7 260 0.5× 147 0.4× 345 1.0× 28 0.2× 36 0.5× 7 502
Steven I. Marlowe United States 8 162 0.3× 111 0.3× 377 1.1× 43 0.2× 69 0.9× 11 571
Lynette Purdue United States 15 572 1.2× 444 1.3× 168 0.5× 140 0.8× 8 0.1× 17 746
Lars Moberg Sweden 10 348 0.7× 472 1.3× 218 0.7× 55 0.3× 7 0.1× 15 641
George McKinley United States 12 227 0.5× 219 0.6× 389 1.2× 39 0.2× 7 0.1× 28 644
Emilio Fumero Spain 12 438 0.9× 437 1.2× 110 0.3× 184 1.0× 15 0.2× 21 603
Thomas Nevin United States 7 268 0.5× 128 0.4× 199 0.6× 172 1.0× 6 0.1× 8 546

Countries citing papers authored by Jane Yeo

Since Specialization
Citations

This map shows the geographic impact of Jane Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Yeo more than expected).

Fields of papers citing papers by Jane Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Yeo. The network helps show where Jane Yeo may publish in the future.

Co-authorship network of co-authors of Jane Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Yeo. A scholar is included among the top collaborators of Jane Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Yeo. Jane Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Brothers, Cindy, Jaime E. Hernández, Amy Cutrell, et al.. (2009). Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(1). 20–28. 133 indexed citations
2.
3.
Gathe, Joseph, Prudence Ive, Robin Wood, et al.. (2004). SOLO. AIDS. 18(11). 1529–1537. 153 indexed citations
4.
Wood, Robin, Keikawus Arastéh, Hans‐Jürgen Stellbrink, et al.. (2003). Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients. Antimicrobial Agents and Chemotherapy. 48(1). 116–123. 36 indexed citations
5.
6.
Mulder, Jan W., David A. Cooper, Eric Sandström, et al.. (1994). Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS. AIDS. 8(3). 313–322. 44 indexed citations
7.
Cooper, David A., P Pehrson, Court Pedersen, et al.. (1993). The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex. AIDS. 7(2). 197–208. 63 indexed citations
8.
Alexander, Graeme, Elizabeth A. Fagan, John E. Hegarty, et al.. (1987). Controlled clinical trial of acyclovir in chronic hepatitis B virus infection. Journal of Medical Virology. 21(1). 81–87. 46 indexed citations
9.
Gibson, John R., Michael Klaber, Susan Harvey, et al.. (1986). Prophylaxis against Herpes labialis with Acyclovir Cream – a Placebo-Controlled Study. Dermatology. 172(2). 104–107. 29 indexed citations
10.
Thin, R N, et al.. (1985). Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial. Journal of Antimicrobial Chemotherapy. 16(2). 219–226. 28 indexed citations
11.
Thomas, Ranjeny, Harold Dodd, Jane Yeo, & J.D. Kirby. (1985). Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection. British Journal of Dermatology. 113(6). 731–735. 25 indexed citations
12.
Fiddian, A. P., et al.. (1983). Successful treatment of herpes labialis with topical acyclovir.. BMJ. 286(6379). 1699–1701. 91 indexed citations
13.
Yeo, Jane & A. P. Fiddian. (1983). Acyclovir in the management of herpes labialis. Journal of Antimicrobial Chemotherapy. 12(suppl B). 95–103. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. de Truchis Breakdown of academic impact, for papers by John Chuah Breakdown of academic impact, for papers by Heribert Knechten Breakdown of academic impact, for papers by Terri Creagh-Kirk Breakdown of academic impact, for papers by Steven I. Marlowe Breakdown of academic impact, for papers by Lynette Purdue Breakdown of academic impact, for papers by Lars Moberg Breakdown of academic impact, for papers by George McKinley Breakdown of academic impact, for papers by Emilio Fumero Breakdown of academic impact, for papers by Thomas Nevin
Rankless by CCL
2026